Npwt denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for npwt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Deny Negative Pressure Wound Therapy (NPWT) as Experimental

Aetna may issue an "experimental or investigational" denial for NPWT in specific clinical contexts — for example, when it is being applied to a wound type, anatomical location, or patient population for which Aetna's clinical policy bulletin does not recognize sufficient evidence of clinical benefit. NPWT is well-established for many wound categories, but Aetna's policies enumerate specific covered indications, and applications outside those enumerated uses may trigger this denial type.

## Why This Denial Is Appealable

An experimental/investigational denial must be grounded in Aetna's published clinical policy criteria and applied consistently with the medical evidence. NPWT devices cleared by the FDA for wound management have a substantial body of peer-reviewed clinical literature supporting their effectiveness across a range of wound types. If your wound falls within — or is clinically analogous to — a category for which accepted medical evidence supports NPWT, and Aetna's policy does not reflect that evidence base, the denial is a strong candidate for reversal on appeal or external review. The IRO in external review assesses whether the service meets the standard of "generally accepted" medical practice, not merely whether it appears on Aetna's approved list.

## Federal Appeal Framework

• Internal appeal: Under ERISA §503 and ACA §2719, you have the right to a full-and-fair internal review. Request a copy of Aetna's clinical policy bulletin for NPWT and the specific finding that placed your case outside covered indications.
• External review: ACA §2719 specifically governs experimental/investigational denials — IRO review is explicitly available for these. The IRO applies a "generally accepted standards of medical practice" standard, which is more favorable than Aetna's internal criteria. File within the four-month external-review window.
• Expedited review: Available when the wound is acute and a treatment delay poses a serious health risk.

## Concrete Appeal Steps and Timeline

1. Obtain Aetna's clinical policy bulletin for NPWT and identify the exact clause used to support the experimental finding. 2. Have the treating wound care clinician or surgeon write a letter explaining how the clinical presentation falls within — or is supported by the same evidence base as — an established NPWT indication. 3. Ask the clinician to reference the relevant professional society guidelines (e.g., from the Wound Healing Society or applicable specialty society) that support NPWT for the wound type at issue. 4. File the internal appeal with the clinician letter and any supporting clinical references. 5. If denied, request external review immediately — IRO review is particularly powerful for experimental-designation denials.

## Documentation to Gather

• Wound characterization: Type, etiology, duration, depth, and prior treatment history, clearly documented by the treating clinician.
• Prior treatment failure: Documentation of conventional wound care methods that were tried, with dates, durations, and outcomes, establishing that NPWT is not a first-line preference but a medically necessary next step.
• Clinician medical-necessity letter: States the wound diagnosis, treatment history, clinical rationale for NPWT, and references the applicable professional society guideline or standard of practice.
• Aetna clinical policy bulletin: Annotated copy highlighting the specific criterion at issue and any internal inconsistencies or gaps in Aetna's evidence analysis.

## Criteria-Mapping Structure

Aetna's clinical policy bulletin sets out the evidence basis for its experimental determination. Use a direct counter-mapping:

| Aetna Experimental-Denial Criterion | Clinical and Literature Counter-Evidence | |---|---| | [Copy the relevant policy language verbatim] | [Clinician note or guideline reference addressing this specific point] |

IRO reviewers respond well to appeals that directly engage the policy language and show, criterion by criterion, why the service meets accepted medical practice standards.